Yours Free! Download the 31-page Report!

Get immediate access to the “The China Medtech Sector with Focus on New Regulatory Rules” by clicking the blue LinkedIn button for immediate access or use the manual signup page if you prefer.

CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET OVERVIEW
2.1. Government Initiatives
2.1.1. 13th Five Year Plan
2.1.2. Healthcare Reform 2020
2.1.3. Made in China 2025
2.1.4. Healthy China 2030
2.2. Chinese Healthcare System
2.2.1. Explosion of Chronic Diseases and Aging
2.2.2. Privatization in Healthcare
2.2.3. Medical Tourism
2.3. Medtech Segments in China
2.3.1. Segment Sizes and Growth Rates
2.3.2. Prices and Tenders
3. IMPORTANT MARKET PLAYERS
3.1. Major International and Domestic Players
3.2. Can Domestic Companies Internationalise?
4. INBOUND AND OUTBOUND M&A
4.1. Inbound M&A
4.2. Domestic-Domestic M&A
4.3. Outbound M&A
5. REGULATORY OVERVIEW
5.1. Order 650
5.2. Fees, Classification and Innovation Channel
5.3. GSP and GMP
6. LOGISTICS AND DISTRIBUTION
6.1. Current System: Inefficient and Fragmented
6.2. Two Invoices System
6.3. Future: State-Run or Private?
7. OPPORTUNITIES AND CHALLENGES FOR SWISS SMES
7.1. Why to Enter and Why Not to Enter?
7.2. Challenges of Medtech SMEs in China
7.3. Case Study: Medtech Start-up to China
8. CONCLUSION / CALL-FOR-ACTION
9. ATTACHMENTS

Thanks to Medical Devices Group member Urs Mattes, for this free gift for our readers.

You can reach him at ursmattes [at] hotmail [dot] com.

If you’re doing business in China – or thinking about it – you’ll value the report.